Trisodium Citrate Dihydrate
Generic Name: trisodium citrate dihydrate
Brand Names:
Sodium Citrate W/v Anticoagulant
11 DESCRIPTION SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is designed to be metered by an apheresis device in apheresis procedures, to prevent platelet activation and coagulation as blood moves throughout the extracorporeal unit (tubing set) in an apheresis procedure. The solution is sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents. Sterilized with steam. The formulas of the active ingredients are provided in Table 1.
Overview
11 DESCRIPTION SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is designed to be metered by an apheresis device in apheresis procedures, to prevent platelet activation and coagulation as blood moves throughout the extracorporeal unit (tubing set) in an apheresis procedure. The solution is sterile and non-pyrogenic, and it contains no bacteriostatic or antimicrobial agents. Sterilized with steam. The formulas of the active ingredients are provided in Table 1.
Uses
1 INDICATIONS AND USAGE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [See Dosage and Administration (2) .] SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. ( 1 )
Dosage
2 DOSAGE AND ADMINISTRATION SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is added to tubing sets during apheresis procedures. ( 2 ) SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP may only be used with apheresis devices. For instructions on the use of the solution see the apheresis device operator's manual. ( 2.1 ) Follow the directions for connecting the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP bag to the apheresis system. ( 2.2 ) 2.1 General Dosing Information SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is added to tubing sets during apheresis procedures. The solution bag is connected to the tubing set in an apheresis collection. The recommended dose is determined by the apheresis device and metered into the tubing set by the apheresis device.
Side Effects
6 ADVERSE REACTIONS Citrate reactions or toxicity may occur with the infusion of blood products to patients and return of blood containing citrate anticoagulant to donors. The recipient of the blood containing citrate should be monitored for the signs and symptoms of citrate toxicity. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease.
Warnings
5 WARNINGS AND PRECAUTIONS Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Use aseptic technique throughout all procedures to ensure donor safety and quality. Single-use container. Do not reuse. Discard any unused or partially used product. Rx only. Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Use aseptic technique throughout all procedures to ensure donor safety and quality. Single-use container, do not reuse. Discard any unused or partially used product. Rx only ( 5 ) 4 CONTRAINDICATIONS DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. ( 4 )
Storage
STORAGE Up to 25 °C. Protect from freezing.
Frequently Asked Questions
What is Trisodium Citrate Dihydrate used for?▼
1 INDICATIONS AND USAGE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [See Dosage and Administration (2) .] SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. ( 1 )
What are the side effects of Trisodium Citrate Dihydrate?▼
6 ADVERSE REACTIONS Citrate reactions or toxicity may occur with the infusion of blood products to patients and return of blood containing citrate anticoagulant to donors. The recipient of the blood containing citrate should be monitored for the signs and symptoms of citrate toxicity. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease.
What are the important warnings for Trisodium Citrate Dihydrate?▼
5 WARNINGS AND PRECAUTIONS Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Use aseptic technique throughout all procedures to ensure donor safety and quality. Single-use container. Do not reuse. Discard any unused or partially used product. Rx only. Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Use aseptic technique throughout all procedures to ensure donor safety and quality. Single-use container, do not reuse. Discard any unused or partially used product. Rx only ( 5 ) 4 CONTRAINDICATIONS DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. ( 4 )
Related Medications
Agrimony, Calochortus Tolmiei, Cimicifuga Racemosa, Clematis Vitalba, Dandelion, Diplacus Aurantiacus, Echinacea Angustifolia, Ehrendorferia Chrysantha, Fuchsia, Hydrastis Canadensis, Kali Phosphoricum, Larix Decidua, Lathyrus Odoratus, Lonicera Caprifolium, Natrum Muriaticum, Rosa Californica, Rosmarinus Officinalis, Stigmata Maidis, Sulphur, Yarrow, Yerba Santa
agrimony, calochortus tolmiei, cimicifuga racemosa, clematis vitalba, dandelion, diplacus aurantiacus, echinacea angustifolia, ehrendorferia chrysantha, fuchsia, hydrastis canadensis, kali phosphoricum, larix decidua, lathyrus odoratus, lonicera caprifolium, natrum muriaticum, rosa californica, rosmarinus officinalis, stigmata maidis, sulphur, yarrow, yerba santa
Uses: For temporary relief of minor: tension* headache* sleep disturbances* fear* fatigue* sluggish mind* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Arnica Montana, Cinchona Officinalis, Cocculus Indicus, Coffea Cruda, Tabacum
arnica montana, cinchona officinalis, cocculus indicus, coffea cruda, tabacum
Non-Standardized Food Allergenic Extract [EPC]
Purpose fatigue, irritability and lethargy mood changes, fatigue and early waking excessive sleepiness, loss of appetite & constipation headache, lightheadedness & inability to concentrate sleeplessness, nausea and anxiety
Chlorhexidine Gluconate And Alcohol
chlorhexidine gluconate and alcohol
Purpose Antiseptic Antiseptic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.